TickerFacts.

Beta Bionics, Inc. (BBNX): Capital Expenditures

Annual figures by period end, from SEC filings.

$5.30M
Year ended 2025-12-31
$5.60M
Trailing 12 months to 2026-06-30
2023-12-31: $402.0K2024-12-31: $3.40M2025-12-31: $5.30M$5.30M
2023-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$5.30M+56.0%2026-02-24, From 2025-01-01
2024-12-31$3.40M+744.5%2026-02-24, From 2024-01-01
2023-12-31$402.0Kn/a2025-03-28, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Beta Bionics, Inc. (BBNX)2025-12-31$5.30M+56.0%
NeuroPace Inc (NPCE)2025-12-31$332.0K+8.5%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$34.89M+52.1%
Pulmonx Corp (LUNG)2025-12-31$452.0K-68.8%
Anika Therapeutics, Inc. (ANIK)2025-12-31$6.83M-11.7%
Orasure Technologies Inc (OSUR)2025-12-31$4.20M+10.5%
Delcath Systems, Inc. (DCTH)2025-12-31$1.55M+176.7%
Iradimed Corp (IRMD)2025-12-31$7.76M-3.0%
TELA Bio, Inc. (TELA)2025-12-31$448.0K-54.7%

Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗